Cleared Traditional

Omnican fine (K173803) - FDA 510(k) Clearance

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K173803 · B.Braun Medical, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2018
Decision
178d
Days
Class 2
Risk

K173803 is an FDA 510(k) clearance for the Omnican fine. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by B.Braun Medical, Inc. (Allentown, US). The FDA issued a Cleared decision on June 11, 2018 after a review of 178 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all B.Braun Medical, Inc. devices

Submission Details

510(k) Number K173803 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 15, 2017
Decision Date June 11, 2018
Days to Decision 178 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
49d slower than avg
Panel avg: 129d · This submission: 178d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 202
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K173803.
Medifine Pen Needle 3 Bevel
K180720 · Medibio USA, LLC · Jun 2018
Kopac Sterile Needle
K172483 · Poonglim Pharmatech, Inc. · Jun 2018
Disposable Sterile Needle
K172938 · Jiangsu Caina Medical Co.,Ltd · Jun 2018
VACUETTE SAFELINK Holder with male luer lock
K180545 · Greiner Bio-One Na, Inc. · May 2018
Sterile Hypodermic Needle for Single Use
K180259 · Jiangsu Shenli Medical Production Co., Ltd. · May 2018
RELI Safety Blood Collection Tube Holder, RELI Blood Collection Tube Holder
K173279 · Myco Medical Supplies, Inc. · May 2018